All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Results of combined radiotherapy and hormonal treatment of prostate cancer patients with initial PSA value >40 ng/ml

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F12%3A00102799" target="_blank" >RIV/00843989:_____/12:00102799 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.rpor.2012.01.006" target="_blank" >http://dx.doi.org/10.1016/j.rpor.2012.01.006</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.rpor.2012.01.006" target="_blank" >10.1016/j.rpor.2012.01.006</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Results of combined radiotherapy and hormonal treatment of prostate cancer patients with initial PSA value >40 ng/ml

  • Original language description

    Aim: To evaluate the outcome of prostate cancer patients with initial PSA value >40ng/ml. Background: The outcome of prostate cancer patients with very high initial PSA value is not known and patients are frequently treated with palliative intent. We analyzed the outcome of radical combined hormonal treatment and radiotherapy in prostate cancer patients with initial PSA value >40ng/ml. Methods: Between January 2003 and December 2007 we treated, with curative intent, 56 patients with non-metastatic prostate cancer and initial PSA value >40 ng/ml. The treatment consisted of two months of neoadjuvant hormonal treatment (LHRH analog), radical radiotherapy (68-78 Gy, conformal technique) and an optional two-year adjuvant hormonal treatment. Results: The median time of follow up was 61 months. 5-Year overall survival was 90%. 5-Year biochemical disease free survival was 62%. T stage, Gleason score, PSA value, and radiotherapy dose did not significantly influence the outcome. Late genitourina

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Reports of practical oncology and radiotherapy

  • ISSN

    1507-1367

  • e-ISSN

  • Volume of the periodical

    17

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    PL - POLAND

  • Number of pages

    6

  • Pages from-to

    79-84

  • UT code for WoS article

  • EID of the result in the Scopus database